-
MOQ
10 Box
- Country of OriginIndia
-
Supply Type
Exporter, Supplier, Retailer, Distributor
-
Preferred Buyer Location
All over the world
What is the success rate of IMFINZI?
Â
Â
Imfinzi treated patients survived on average 17 months without cancer progression compared to only 6 months for those treated with placebo. Trial results were updated in 2022. Overall 50% of Imfinzi treated patients survived 4 years from treatment compared to 36% of those treated with chemoradiation without Imfinzi.
View More Details